Long-Term Myocardial Effects of Correction of Anemia With Recombinant Human Erythropoietin in Aged Patients on Hemodialysis
- 1 April 1992
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 19 (4) , 353-357
- https://doi.org/10.1016/s0272-6386(12)80453-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Hemodynamic Effects of Partial Correction of Chronic Anemia by Recombinant Human Erythropoietin in Patients on DialysisAmerican Journal of Kidney Diseases, 1991
- Therapy with Recombinant Human Erythropoietin Reduces Cardiac Size and Improves Heart Function in Chronic Hemodialysis PatientsAmerican Journal of Nephrology, 1991
- Hemodynamic Changes in Hemodialyzed Patients during Treatment with Recombinant Human ErythropoietinNephron, 1991
- Hemodynamic changes by recombinant erythropoietin therapy in hemodialyzed patients.Hypertension, 1990
- Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietinThe Lancet, 1990
- Vascular changes in hemodialysis patients in response to recombinant human erythropoietinKidney International, 1989
- Left Ventricular Hypertrophy in End-Stage Renal DiseaseNephron, 1988
- Uremic cardiomyopathy: An inadequate left ventricular hypertrophyKidney International, 1987
- Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.Circulation, 1977
- Congestive cardiomyopathy in uraemic patients on long term haemodialysis.BMJ, 1977